AnalystsInsight

Alfredo Alonso Estudillo (Deutsche Bank ): Analyst Track Record and Price‑Target Accuracy

How often Alfredo Alonso Estudillo’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 0 ratings, compared with the average Wall Street analyst.

3 min readHow we research

Key takeaways

  • Alfredo Alonso Estudillo ranks #15 of 1,000 analysts in Exent’s scoring (5.0★).
  • — of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: — days; — of calls were up 12 months later.
  • Most‑covered stocks: BME-BBVA, BME-SAN, BME-UNI, BME-CABK.

Alfredo Alonso Estudillo’s track record at a glance

Alfredo Alonso Estudillo of Deutsche Bank ranks #15 of the 1,000 analysts Exent scores, with a 5.0★ rating and a focus on financials. Over a 7‑year lookback, — of Alfredo’s price targets were reached, the 52.4% average across all analysts.

MetricAlfredo Alonso EstudilloAll analysts
Price‑target hit rate—52.4%
Median days to hit target—91 days
Calls up after 12 months—64.0%
Median 12‑month return of calls—+13.4%
Hit rate, last 2 years——
Average worst drop after a call——
Ratings in the sample0—
Stocks covered12—

How fast price targets were reached

Time to reach the targetAlfredo Alonso Estudillo
Under 30 days—
30–90 days—
90–180 days—
Over 180 days—

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Alfredo Alonso Estudillo covers most

StockRatings in the sample
BME-BBVA82
BME-SAN71
BME-UNI36
BME-CABK35
BME-BKT33
FRA-NAGF28
BME-SAB25
FRA-5ZT24

In the past year Alfredo’s ratings were 75% Buy, 21% Hold and 4% Sell.

Recent ratings (shown with a 30-day delay)

DateStockActionRatingPrice target
Aug 6, 2026BME-UNIReiterated: HoldHold$3.25
Aug 4, 2026BME-BBVADowngraded: HoldHold$23.65
Aug 4, 2026BME-CABKReiterated: HoldHold$12.05
Aug 4, 2026BME-SABReiterated: BuyBuy$3.75
Jul 28, 2026BME-BKTReiterated: BuyBuy$17.50
Jul 27, 2026BME-SANReiterated: BuyBuy$13.55
Jul 23, 2026BME-SANReiterated: BuyBuy$12.10
Jun 5, 2026FRA-318MaintainedBuy$11.25
Jun 5, 2026FRA-1X8MaintainedBuy$5.00
Jun 5, 2026FRA-1X8Maintained: BuyBuy$5.00
Jun 5, 2026FRA-NAGFMaintainedBuy$17.10
Jun 5, 2026FRA-NAGFMaintained: BuyBuy$17.10
  • Aug 6, 2026
    Stock
    BME-UNI
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $3.25
  • Aug 4, 2026
    Stock
    BME-BBVA
    Action
    Downgraded: Hold
    Rating
    Hold
    Price target
    $23.65
  • Aug 4, 2026
    Stock
    BME-CABK
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $12.05
  • Aug 4, 2026
    Stock
    BME-SAB
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $3.75
  • Jul 28, 2026
    Stock
    BME-BKT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $17.50
  • Jul 27, 2026
    Stock
    BME-SAN
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $13.55
  • Jul 23, 2026
    Stock
    BME-SAN
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $12.10
  • Jun 5, 2026
    Stock
    FRA-318
    Action
    Maintained
    Rating
    Buy
    Price target
    $11.25
  • Jun 5, 2026
    Stock
    FRA-1X8
    Action
    Maintained
    Rating
    Buy
    Price target
    $5.00
  • Jun 5, 2026
    Stock
    FRA-1X8
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $5.00
  • Jun 5, 2026
    Stock
    FRA-NAGF
    Action
    Maintained
    Rating
    Buy
    Price target
    $17.10
  • Jun 5, 2026
    Stock
    FRA-NAGF
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $17.10

Live ratings from Alfredo Alonso Estudillo and the other top‑ranked analysts, and the stocks where they agree, are in Exent Stocks Radar.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 12, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Stocks Radar shows Alfredo Alonso Estudillo’s live ratings and those of the other top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Alfredo Alonso Estudillo ranks #15 of 1,000 with a 5.0★ rating. — of price targets were reached over a 7-year lookback (all analysts: 52.4%), and — of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Alfredo Alonso Estudillo’s success rate is 90.3% by the ranking source and — by Exent’s price-target hit-rate backtest, with a median of — days to reach a target.

Alfredo Alonso Estudillo (Deutsche Bank ) covers 12 stocks, mostly in financials. The most frequently rated are BME-BBVA, BME-SAN, BME-UNI, BME-CABK, BME-BKT.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full Gems access· full Gems access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.